Bio Protocol vs io.net — how do they compare? Bio Protocol trades at Rp439.3 (market cap Rp997,34M, Rp163,74M 24h volume), while io.net trades at Rp1,970 (market cap Rp758,36M, Rp401,12M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 381,5M / 800M IO (48%) for io.net. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and io.net for 34 Days on average.
| BIO | IO | |
|---|---|---|
Market Cap | Rp997,34M | Rp758,36M |
Volume (24h) | Rp163,74M | Rp401,12M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 381,5M / 800M IO (48%) |
Typical Hold Time | 18 Days | 34 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
IO token trades at Rp 2,004, showing bearish technical signals with 18 sell indicators and strong selling pressure from moving averages. The price is near the pivot point of Rp 2,028, with support at Rp 1,954 and resistance at Rp 2,107. Circulating supply is 48% of max, with an average hold time of 34 days, indicating moderate network participation.
Overall outlook is cautious due to bearish momentum and neutral fundamentals. Key opportunities include potential rebounds from oversold RSI levels, while risks involve low liquidity and high volatility. Investors should monitor support breaks and ecosystem updates for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →io.net, formerly known as ANTBIT, leverages a decentralized computing network powered by Solana and Aptos to provide machine learning engineers with access to distributed cloud clusters. It aims to address challenges like limited availability, poor choice, and high costs associated with accessing GPUs in the public cloud.
Read more on IO →